[Responsible risks in the choice of palliative chemotherapy].
The risk of tumor chemotherapy is weighed against its therapeutical potential. If there is a chance of a curative or life-prolonging treatment, the choice of a rather aggressive form of chemotherapy is justified. In the majority of patients with metastatic malignant diseases, however, life-prolongation is not achievable and the choice of a chemotherapy with life-threatening side-effects contra-indicated. Potential benefits and risk of chemotherapy are further exemplified in breast cancer.
D000970:Antineoplastic Agents / Q000009:adverse effects*; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy* / Q000401:mortality; D010166:Palliative Care; D012306:Risk
D000970:Antineoplastic Agents
Verantwortbare Risiken bei der Wahl der palliativen Chemotherapie.